Financhill
Sell
22

NXRT Quote, Financials, Valuation and Earnings

Last price:
$42.48
Seasonality move :
-2%
Day range:
$41.04 - $42.96
52-week range:
$28.20 - $48.37
Dividend yield:
4.46%
P/E ratio:
24.30x
P/S ratio:
4.19x
P/B ratio:
2.42x
Volume:
851.6K
Avg. volume:
125.6K
1-year change:
25.28%
Market cap:
$1.1B
Revenue:
$277.5M
EPS (TTM):
$1.75
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $181.1M $204.8M $219.2M $264M $277.5M
Revenue Growth (YoY) 23.51% 13.11% 7.05% 20.39% 5.14%
 
Cost of Revenues $87.5M $98.8M $102.2M $120.1M $119.9M
Gross Profit $93.6M $106M $117.1M $143.9M $157.6M
Gross Profit Margin 51.7% 51.76% 53.39% 54.51% 56.78%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $9.6M $10M $12M $14.7M $17.1M
Other Inc / (Exp) $121.9M $66M $34.5M $19.9M $112.5M
Operating Expenses $78.7M $92.4M $98.8M $112.3M $112.3M
Operating Income $14.9M $13.6M $18.2M $31.6M $45.3M
 
Net Interest Expenses $37.4M $35.4M $29.6M $60.7M $113.3M
EBT. Incl. Unusual Items $99.4M $44.2M $23.1M -$9.3M $44.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $99.4M $44.2M $23.1M -$9.3M $44.4M
 
Minority Interest in Earnings -$298K -$132K -$69K $31K -$169K
Net Income to Common Excl Extra Items $99.1M $44M $23M -$9.3M $44.3M
 
Basic EPS (Cont. Ops) $4.11 $1.78 $0.92 -$0.36 $1.73
Diluted EPS (Cont. Ops) $4.03 $1.74 $0.89 -$0.36 $1.69
Weighted Average Basic Share $24.1M $24.7M $25.2M $25.6M $25.7M
Weighted Average Diluted Share $24.6M $25.2M $25.8M $25.6M $26.2M
 
EBITDA $205.9M $159.1M $137.4M $146.3M $250M
EBIT $136.8M $76.7M $50.5M $48.6M $154.8M
 
Revenue (Reported) $181.1M $204.8M $219.2M $264M $277.5M
Operating Income (Reported) $14.9M $13.6M $18.2M $31.6M $45.3M
Operating Income (Adjusted) $136.8M $76.7M $50.5M $48.6M $154.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $51M $56.4M $68.1M $69.8M $64.1M
Revenue Growth (YoY) 8.88% 10.58% 20.69% 2.63% -8.22%
 
Cost of Revenues $24.6M $26.1M $28M $30.8M $29.1M
Gross Profit $26.4M $30.3M $40M $39.1M $35M
Gross Profit Margin 51.72% 53.74% 58.8% 55.95% 54.64%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.8M $3.2M $3.8M $4.9M $4.8M
Other Inc / (Exp) $31.2M -$3.2M $5.8M $53.3M $12.1M
Operating Expenses $20.5M $24.7M $29M $28.7M $29.4M
Operating Income $5.8M $5.6M $11M $10.4M $5.6M
 
Net Interest Expenses $7.4M $7.8M $17.4M $29.8M $26.6M
EBT. Incl. Unusual Items $29.6M -$5.4M -$599K $33.9M -$8.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $29.6M -$5.4M -$599K $33.9M -$8.9M
 
Minority Interest in Earnings -$89K $16K $2K -$129K $35K
Net Income to Common Excl Extra Items $29.6M -$5.4M -$597K $33.7M -$8.9M
 
Basic EPS (Cont. Ops) $1.21 -$0.21 -$0.02 $1.31 -$0.35
Diluted EPS (Cont. Ops) $1.19 -$0.21 -$0.02 $1.28 -$0.35
Weighted Average Basic Share $24.4M $25.2M $25.6M $25.7M $25.4M
Weighted Average Diluted Share $24.9M $25.2M $25.6M $26.3M $25.4M
 
EBITDA $54M $23.4M $41.3M $86.8M $41.7M
EBIT $36.3M $1.8M $16.1M $63M $17.1M
 
Revenue (Reported) $51M $56.4M $68.1M $69.8M $64.1M
Operating Income (Reported) $5.8M $5.6M $11M $10.4M $5.6M
Operating Income (Adjusted) $36.3M $1.8M $16.1M $63M $17.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $203.9M $211.3M $253.1M $278M $264.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $97.9M $100.3M $114.6M $123.2M $115M
Gross Profit $106M $111M $138.5M $154.8M $149.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $10.7M $10.7M $14M $16.5M $18.8M
Other Inc / (Exp) $59M -$9.1M $49M $93.1M $123.8M
Operating Expenses $96.6M $92.9M $113M $110.5M $116.4M
Operating Income $9.4M $18.1M $25.5M $44.3M $33.4M
 
Net Interest Expenses $33.4M $28.9M $48.7M $107.5M $110.6M
EBT. Incl. Unusual Items $35.1M -$19.9M $25.7M $29.8M $46.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $35.1M -$19.9M $25.7M $29.8M $46.6M
 
Minority Interest in Earnings -$105K $60K -$70K -$114K -$181K
Net Income to Common Excl Extra Items $35M -$19.9M $25.7M $29.7M $46.4M
 
Basic EPS (Cont. Ops) $1.32 -$0.79 $1.04 $1.16 $1.80
Diluted EPS (Cont. Ops) $1.28 -$0.79 $1.01 $1.13 $1.75
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $153.6M $89M $170.8M $228.5M $252M
EBIT $67.8M $6.7M $71.8M $134.4M $154.4M
 
Revenue (Reported) $203.9M $211.3M $253.1M $278M $264.8M
Operating Income (Reported) $9.4M $18.1M $25.5M $44.3M $33.4M
Operating Income (Adjusted) $67.8M $6.7M $71.8M $134.4M $154.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $154.3M $160.7M $194.6M $208.6M $195.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $74.3M $75.8M $88.2M $91.3M $86.4M
Gross Profit $80M $85M $106.4M $117.4M $109.6M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $8.4M $9.1M $11.1M $12.9M $14.5M
Other Inc / (Exp) $67.4M -$7.7M $6.8M $76.5M $87.7M
Operating Expenses $70.9M $71.4M $85.6M $83.8M $87.9M
Operating Income $9.1M $13.5M $20.8M $33.5M $21.7M
 
Net Interest Expenses $28.1M $21.6M $40.7M $84M $81.2M
EBT. Incl. Unusual Items $48.4M -$15.7M -$13.1M $26M $28.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $48.4M -$15.7M -$13.1M $26M $28.2M
 
Minority Interest in Earnings -$145K $47K $46K -$99K -$111K
Net Income to Common Excl Extra Items $48.2M -$15.7M -$13M $25.9M $28M
 
Basic EPS (Cont. Ops) $1.93 -$0.62 -$0.50 $1.01 $1.08
Diluted EPS (Cont. Ops) $1.89 -$0.62 -$0.50 $0.98 $1.05
Weighted Average Basic Share $74.1M $75.4M $76.9M $77M $76.7M
Weighted Average Diluted Share $75.1M $75.4M $76.9M $77.6M $78.1M
 
EBITDA $136.8M $66.6M $100.1M $178.7M $180.7M
EBIT $74.3M $4.3M $25.6M $107.8M $107.3M
 
Revenue (Reported) $154.3M $160.7M $194.6M $208.6M $195.9M
Operating Income (Reported) $9.1M $13.5M $20.8M $33.5M $21.7M
Operating Income (Adjusted) $74.3M $4.3M $25.6M $107.8M $107.3M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $25.7M $24.5M $49.5M $16.8M $12.4M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $6.3M $9M $4.8M $17.1M $14.6M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $123.8M $66.1M $93.5M $158.4M $170.6M
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $6.2M $1.1M $1.5M -- --
Other Long-Term Assets $2.3M $2.4M $4.7M $10.4M $8.6M
Total Assets $1.9B $1.8B $2.1B $2.2B $2.1B
 
Accounts Payable $12M $10.1M $12.6M $12.3M $17.1M
Accrued Expenses $3.7M $2.3M $2.5M $7.9M $9.4M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $41.2M -- -- $68M $88M
Total Current Liabilities $287.2M $209.1M $308.3M $170M $150.8M
 
Long-Term Debt $1.1B $1.2B $1.3B $1.5B $1.5B
Capital Leases -- -- -- -- --
Total Liabilities $1.4B $1.4B $1.6B $1.7B $1.6B
 
Common Stock $251K $250K $255K $255K $256K
Other Common Equity Adj $2.5M -$44.4M $2.6M $102.2M $69.9M
Common Equity $426.2M $407.9M $469.8M $519.7M $494.6M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $3.3M $3.1M $6.1M $5.6M $5.2M
Total Equity $429.5M $411M $476M $525.3M $499.9M
 
Total Liabilities and Equity $1.9B $1.8B $2.1B $2.2B $2.1B
Cash and Short Terms $25.7M $24.5M $49.5M $16.8M $12.4M
Total Debt $1.4B $1.3B $1.6B $1.6B $1.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $70.3M $18.4M $15.8M $7.5M $17.4M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $10.8M $5.8M $11.5M $14.7M $12.7M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $119.4M $117.1M $188.8M $198.4M $93.7M
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $9.8M $5.8M $9.9M $13.3M $9.4M
Total Assets $1.8B $2B $2.3B $2.2B $2B
 
Accounts Payable $12.5M $11.5M $13.9M $19M $12.2M
Accrued Expenses $2.2M $2.4M $6M $9.5M $8.6M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- $40.5M $82.7M $112M --
Total Current Liabilities $249.8M $349.9M $460.2M $204.4M $42.5M
 
Long-Term Debt $1.1B $1.2B $1.3B $1.5B $1.5B
Capital Leases -- -- -- -- --
Total Liabilities $1.4B $1.6B $1.7B $1.7B $1.5B
 
Common Stock $244K $252K $255K $256K $254K
Other Common Equity Adj -$51.9M -$13.4M $109.1M $97.4M $39.9M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $3.2M $4.5M $5.8M $5.1M $5.9M
Total Equity $394.2M $410M $537.4M $518.9M $453.1M
 
Total Liabilities and Equity $1.8B $2B $2.3B $2.2B $2B
Cash and Short Terms $70.3M $18.4M $15.8M $7.5M $17.4M
Total Debt $1.3B $1.5B $1.6B $1.5B $1.5B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $99.4M $44.2M $23.1M -$9.3M $44.4M
Depreciation & Amoritzation $69.1M $82.4M $86.9M $97.6M $95.2M
Stock-Based Compensation $5.1M $5.5M $7M $7.9M $9.3M
Change in Accounts Receivable -- -- -$3.1M -$10.7M -$8.1M
Change in Inventories -- -- -- -- --
Cash From Operations $51.4M $57.2M $73.3M $79.1M $96.6M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$553.1M $11.5M -$235.9M -$162.3M $51.9M
 
Dividends Paid (Ex Special Dividend) -$28M -$32.3M -$35.8M -$40.6M -$44.8M
Special Dividend Paid
Long-Term Debt Issued $678.1M $81.5M $494.6M $940.8M $42.8M
Long-Term Debt Repaid -$182.8M -$141.9M -$284.6M -$820.4M -$149.1M
Repurchase of Common Stock -- -$44.5M -- -$11.1M --
Other Financing Activities -$7.3M -$3.3M -$5.5M -$26.3M -$3.9M
Cash From Financing $529.8M -$82.9M $194.3M $46.3M -$155M
 
Beginning Cash (CF) $43.1M $71.2M $57M $88.7M $51.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $28.1M -$14.2M $31.7M -$36.9M -$6.5M
Ending Cash (CF) $71.2M $57M $88.7M $51.8M $45.3M
 
Levered Free Cash Flow $51.4M $57.2M $73.3M $79.1M $96.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $29.6M -$5.4M -$599K $33.9M -$8.9M
Depreciation & Amoritzation $17.7M $21.6M $25.2M $23.8M $24.6M
Stock-Based Compensation $1.4M $1.8M $2M $2.5M $2.7M
Change in Accounts Receivable -- -- -$3.5M -$3.3M -$986K
Change in Inventories -- -- -- -- --
Cash From Operations $20.6M $27M $30.9M $27.8M $27.8M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -$46K -- -- -- --
Cash From Investing $40.8M -$83.2M -$14.1M $54.3M -$9.9M
 
Dividends Paid (Ex Special Dividend) -$7.6M -$8.6M -$9.7M -$10.8M -$11.7M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $76.2M -- -- --
Long-Term Debt Repaid -$39.7M -$10.2M -$333K -$62.2M -$70K
Repurchase of Common Stock -- $262K -$6M -- --
Other Financing Activities -$295K -$653K -$41K -$2M -$48K
Cash From Financing -$37.8M $63.3M -$16.4M -$75.3M -$11.9M
 
Beginning Cash (CF) $85M $60.2M $66.2M $43M $54.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $23.6M $7.1M $397K $6.9M $6.1M
Ending Cash (CF) $108.6M $67.3M $66.6M $49.8M $60.7M
 
Levered Free Cash Flow $20.6M $27M $30.9M $27.8M $27.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $35.1M -$19.9M $25.7M $29.8M $46.6M
Depreciation & Amoritzation $85.9M $82.3M $99M $94.1M $97.6M
Stock-Based Compensation $5.3M $6.6M $7.7M $9M $10.2M
Change in Accounts Receivable -- -- -- -$10.9M -$3.2M
Change in Inventories -- -- -- -- --
Cash From Operations $58.9M $68.6M $84.9M $91.3M $82M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -$5.1M $5.1M -- -- --
Cash From Investing -$156.7M -$310.9M -$192.5M $35.2M $148.6M
 
Dividends Paid (Ex Special Dividend) -$31.6M -$34.7M -$39.5M -$43.7M -$48.2M
Special Dividend Paid
Long-Term Debt Issued $278.8M $439.5M $234.9M $850.3M --
Long-Term Debt Repaid -$110M -$225.8M -$92.1M -$927.3M -$153.5M
Repurchase of Common Stock -$44.5M -- -- -- --
Other Financing Activities -$5.6M -$5.1M -$8.3M -$22.3M -$3.3M
Cash From Financing $144.9M $200.9M $106.9M -$143.3M -$219.7M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $47.1M -$41.3M -$669K -$16.8M $10.9M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $58.9M $68.6M $84.9M $91.3M $82M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $48.4M -$15.7M -$13.1M $26M $28.2M
Depreciation & Amoritzation $62.5M $62.3M $74.5M $70.9M $73.4M
Stock-Based Compensation $4.1M $5.2M $5.9M $7M $7.9M
Change in Accounts Receivable -- -- -$7.7M -$8M -$3.1M
Change in Inventories -- -- -- -- --
Cash From Operations $46.5M $57.9M $69.6M $81.8M $67.1M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -$5.1M -- -- -- --
Cash From Investing $99.4M -$223M -$179.5M $18M $114.7M
 
Dividends Paid (Ex Special Dividend) -$23.8M -$26.2M -$29.9M -$32.9M -$36.3M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $35M $393M $133.3M $42.8M --
Long-Term Debt Repaid -$109.7M -$193.6M -$1.1M -$107.9M -$112.4M
Repurchase of Common Stock -$44.5M $0 -$11.1M -- -$14.6M
Other Financing Activities -$2.4M -$4.2M -$7M -$3.1M -$2.4M
Cash From Financing -$108.5M $175.3M $87.9M -$101.7M -$166.4M
 
Beginning Cash (CF) $261.8M $169.9M $287M $141.9M $168.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $37.4M $10.3M -$22.1M -$2M $15.4M
Ending Cash (CF) $299.2M $180.1M $265M $139.9M $184.1M
 
Levered Free Cash Flow $46.5M $57.9M $69.6M $81.8M $67.1M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock